Alembic Pharma's partner launches drug for depressive disorder

Alembic Pharma had received approval of its ANDA of desvenlafaxine succinate extended release tablets of strengths 50 mg and 100 mg in June 2015.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news